FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma GrowthIsabelle Tancioni, David D. Schlaepfer, Sean Uryu et al.|Molecular Cancer Therapeutics|2014Cited by 62
Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancerNina R. Shah, David D. Schlaepfer, Isabelle Tancioni et al.|Gynecologic Oncology|2014Cited by 54
Low merlin level is a biomarker for the sensitivity of ovarian carcinoma cells to focal adhesion kinase (FAK) inhibitionNina R. Shah, David D. Schlaepfer, Isabelle Tancioni et al.|Gynecologic Oncology|2014Cited by 0
Data from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma GrowthIsabelle Tancioni, David D. Schlaepfer, Nichol Miller et al.|Unknown|2023Cited by 0
Supplementary Figure 5 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma GrowthIsabelle Tancioni, David D. Schlaepfer, Sean Uryu et al.|Unknown|2023Cited by 0